Renal haemodynamics and natriuretic responses to intravenous administration of diadenosine tetraphosphate (Ap4A) and nicotinamide adenine dinucleotide (NAD) in rat

被引:0
作者
Szczepanska-Konkel, M
Langner, G
Bednarczuk, G
Stiepanow-Trzeciak, A
Jankowski, M
Angielski, S
机构
[1] Med Univ Gdansk, Dept Clin Chem, PL-80211 Gdansk, Poland
[2] Med Univ Gdansk, Dept Lab Med, PL-80211 Gdansk, Poland
[3] Med Univ Gdansk, Dept Immunopathol, PL-80211 Gdansk, Poland
[4] Polish Acad Sci, Med Res Ctr, Lab Cellular & Mol Nephrol, Gdansk, Poland
来源
JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 2003年 / 54卷 / 02期
关键词
GFR; NAD; diadenosine tetraphosphate;
D O I
暂无
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Effects of Ap4A and NAD - precursor of adenosine, on renal plasma flow (RPF), glomerular filtration rate (GFR) and urine excretion were determined in the anaesthetised rats. Infusion of Ap4A or NAD (i.v., bolus - 1 mumol/kg followed by 10 nmol/min/kg) decreased RPF and GFR (by 30 and 40%, respectively). In spite of GFR reduction during Ap4A infusion, the significant increase in sodium excretion and urine flow was noticed: fractional sodium (FENa) and urine excretion (FEurine) rose 15-fold and 2.5-fold in comparision with the control value, respectively. In contrast to Ap4A, NAD-induced decrease in GFR was associated with parallel decrease in sodium and urine excretion, thus the FENa and FEurine did not significantly change. Pretreatment with adenosine deaminase (adenosine degrading enzyme, 2 U/min/kg) or theophylline (P1-receptors antagonist, 0.2 mmol/min/kg) ceased responses to NAD, wherease Ap4A-induced changes were not affected. Pre-treatment with suramin (P2-receptors antagonist, (i.v., bolus - 12 mg/kg followed by 1.2 mg/min/kg)) completely abolished the renal effects of Ap4A. We conclude that Ap4A may exert specific action on renal function. It acts different from NAD that modified renal function through its hydrolysis product - adenosine. Ap4A might reduce glomerular filtration rate and evoke natriuresis and diuresis, and its effects are probably mediated through stimulation of P2-receptors.
引用
收藏
页码:163 / 173
页数:11
相关论文
共 32 条
  • [1] RENAL EFFECTS OF SELECTIVE ADENOSINE RECEPTOR AGONISTS IN ANESTHETIZED RATS
    CHURCHILL, PC
    BIDANI, A
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 252 (02): : F299 - F303
  • [2] SUBCELLULAR-DISTRIBUTION STUDIES OF DIADENOSINE POLYPHOSPHATES AP4A AND AP5A IN BOVINE ADRENAL-MEDULLA - PRESENCE IN CHROMAFFIN GRANULES
    DELCASTILLO, AR
    TORRES, M
    DELICADO, EG
    MIRASPORTUGAL, MT
    [J]. JOURNAL OF NEUROCHEMISTRY, 1988, 51 (06) : 1696 - 1703
  • [3] ABUNDANT AMOUNTS OF DIADENOSINE 5',5'''-P1,P4-TETRAPHOSPHATE ARE PRESENT AND RELEASABLE, BUT METABOLICALLY INACTIVE, IN HUMAN-PLATELETS
    FLODGAARD, H
    KLENOW, H
    [J]. BIOCHEMICAL JOURNAL, 1982, 208 (03) : 737 - 742
  • [4] Mesenteric and renal vascular effects of diadenosine polyphosphates (APnA)
    Gabriëls, G
    Rahn, KH
    Schlatter, E
    Steinmetz, M
    [J]. CARDIOVASCULAR RESEARCH, 2002, 56 (01) : 22 - 32
  • [5] HYDROLYSIS OF DIADENOSINE 5',5''-P',P''-TRIPHOSPHATE (AP3A) BY PORCINE AORTIC ENDOTHELIAL-CELLS
    GOLDMAN, SJ
    GORDON, EL
    SLAKEY, LL
    [J]. CIRCULATION RESEARCH, 1986, 59 (03) : 362 - 366
  • [6] REGIOSPECIFICITY OF THE HYDROLYSIS OF DIADENOSINE POLYPHOSPHATES CATALYZED BY 3 SPECIFIC PYROPHOSPHOHYDROLASES
    GURANOWSKI, A
    BROWN, P
    ASHTON, PA
    BLACKBURN, GM
    [J]. BIOCHEMISTRY, 1994, 33 (01) : 235 - 240
  • [7] Hohage H, 1996, J AM SOC NEPHROL, V7, P1216
  • [8] The activation of P-1- and P-2-purinoceptors in the guinea-pig left atrium by diadenosine polyphosphates
    Hoyle, CHV
    Ziganshin, AU
    Pintor, J
    Burnstock, G
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (05) : 1294 - 1300
  • [9] Effects of diadenosine polyphosphates on systemic and regional hemodynamics in anesthetized rats
    Khattab, M
    Hohage, H
    Hollah, P
    Rahn, KH
    Schlatter, E
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 1998, 21 (01) : 42 - 49
  • [10] Clinical application of diadenosine tetraphosphate (Ap4A:F-1500) for controlled hypotension
    Kikuta, Y
    Ohiwa, E
    Okada, K
    Watanabe, A
    Haruki, S
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1999, 43 (01) : 82 - 86